Anika Therapeutics Inc (NASDAQ:ANIK)

45.07
Delayed Data
As of Jun 18
 +0.02 / +0.04%
Today’s Change
30.91
Today|||52-Week Range
69.81
-16.40%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Anika Therapeutics Inc have a median target of 52.50, with a high estimate of 71.00 and a low estimate of 39.00. The median estimate represents a +16.49% increase from the last price of 45.07.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Anika Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.33
Sales
$28.8M
Reporting Date
Aug 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 170.65%
 
 
 
 
 
 
Growthannually -57.40%
 
 
 
 
 
 

Sales

Growthquarterly 35.30%
 
 
 
 
 
 
Growthannually -0.67%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.